This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q2 results reflect higher revenues and membership growth.
Cigna (CI) Earnings Surpass Estimates in Q2, Improve Y/Y
by Zacks Equity Research
Cigna's (CI) Q2 earnings gain from a strong fundamental performance and reduced medical costs from delayed treatments amid the COVID-19 pandemic.
Teladoc (TDOC) Q2 Earnings Lag Estimates, Revenues Up Y/Y
by Zacks Equity Research
Teladoc's (TDOC) second-quarter results reflect higher revenues and solid rise in patient visits, partially offset by increased expenses.
Stock Market News for Jul 30, 2020
by Zacks Equity Research
Benchmarks closed higher on Wednesday as investors cheered news that the Federal Reserve has left benchmark interest rates unchanged near zero, along with rally in tech stocks and upbeat quarterly earnings report.
Anthem (ANTM) Q2 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q2 results reflect higher premium revenues and a solid contribution from Government business.
Community Health (CYH) Q2 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Community Health's (CYH) second-quarter results reflect lower costs, partially offset by softer revenues owing to decline in admissions.
5 Healthcare Stocks to Beat on Q2 Earnings Despite Coronavirus
by Zacks Equity Research
Companies across the healthcare sector experience a mixed impact from coronavirus. While some gain traction from a surge in virtual care, the rest suffers demand woes and supply-chain glitches.
Universal Health (UHS) Q2 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Universal Health's (UHS) second-quarter earnings reflect lower expenses, partially offset by reduced patient volumes.
Molina Healthcare's Buyout Deal to Boost Its Base in Kentucky
by Zacks Equity Research
Molina Healthcare's (MOH) upcoming acquisition will fortify its presence in the Kentucky market.
Humana Ties Up With DCI's Affiliate to Serve Members With CKD
by Zacks Equity Research
Humana (HUM) ties up with DCI and its affiliate REACH Kidney Care to offer improved health outcomes for CKD patients in Alabama, North Carolina, South Carolina, and Tennessee.
Quiet Week Could be the Calm Before the Storm
by David Borun
A busy week of earnings reports and Congressional stimulus talks has t
Centene, Quartet Extend Ties for Mental Health Solutions
by Zacks Equity Research
Centene (CNC) and Quartet Health extend their collaboration to deliver behavioral health care services nationwide.
Has UnitedHealth Group (UNH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?
UnitedHealth Beats: Healthcare ETFs in Focus
by Sweta Killa
UnitedHealth Group reported stronger-than-expected second-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues.
Stock Market News for Jul 16, 2020
by Zacks Equity Research
Benchmarks edged up on Wednesday as investors cheered promising data for a potential COVID-19 vaccine and few better-than-expected quarterly earnings reports.
3 Reasons Why UnitedHealth (UNH) Is a Great Growth Stock
by Zacks Equity Research
UnitedHealth (UNH) could produce exceptional returns because of its solid growth attributes.
UnitedHealth's Unit Ties Up With Boulder Community Health
by Zacks Equity Research
UnitedHealth's (UNH) Optum reaches an agreement with Boulder Community Health to provide better medical services to communities in the Boulder County as well as its surroundings.
Why You Should Add Molina Healthcare (MOH) to Your Portfolio
by Zacks Equity Research
Riding high on its strategic initiatives and a solid top line, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
Q2 Earnings in Focus
by Zacks Equity Research
Q2 Earnings in Focus
Goldman Boosts Dow with Best Quarter in Years
by Mark Vickery
Goldman simply blew the doors off Q2 expectations, posting $6.26 per share on $13.3 billion in quarterly revenues which compare very favorably with the $3.97 per share and $10.07 billion in the Zacks consensus.
UnitedHealth's (UNH) Earnings in Q2 Beat on Lower Payouts
by Zacks Equity Research
UnitedHealth's (UNH) Q2 earnings outperformance is driven by a temporary postponement of care in the company's risk-based businesses amid the plaguing pandemic .
UnitedHealth Group (UNH) Tops Q2 Earnings Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 37.45% and -2.62%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
UnitedHealth's Therapy to Guide People With Type 2 Diabetes
by Zacks Equity Research
UnitedHealth (UNH) rolls out a digital health therapy - Level2, which will result in improved health outcomes for people with type 2 diabetes.
Why Earnings Season Could Be Great for UnitedHealth Group (UNH)
by Zacks Equity Research
UnitedHealth Group (UNH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Dow ETF Going Into Q2 Earnings
by Sweta Killa
With most blue-chip companies earnings scheduled over the coming days, investors should closely monitor the movement of the Dow ETF and grab an opportunity that arises from a surge in any of the 30 stocks.